July 6, 2016 / 7:17 AM / a year ago

BUZZ-Nicox: Jumps on study results

** French ophthalmic company's shares up 11 pct on study phase 3 positive results

** Reported with Bausch + Lomb that latanoprostene bunod (LBN) ophthalmic solution 0.024 pct phase 3 study demonstrates significantly greater efficacy versus Timolol maleate 0.5 pct

** Stock on track for best day in >6 mo

** By far top performer of Euronext Next 150 (-0.5 pct)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below